Project Grant HT94252510290
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$473K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90024, USA
Similar Awards
The Defense Health Agency awarded a $468,000 Project Grant to the University of California, Los Angeles under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research developing new therapeutic strategies to target TROP2 in aggressive prostate cancer. The two-year award beginning March 15, 2023 will fund research efforts to investigate medical solutions for prostate cancer on the battlefield and transform health care for service members and the public...
The University of California, Los Angeles (UCLA) has been awarded a $626,081 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program, administered by the Defense Health Agency. The grant, titled "Combinatorial Phenotype-Targeted Therapy to Overcome Mechanisms Driving Prostate Cancer Treatment Resistance," will support advanced biomedical research to transform healthcare for military service members and the broader public. The research...
The Department of the Army Medical Command awarded a $1,559,475 Project Grant to the University of California, Los Angeles under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support integrated meta-analysis of prostate cancer genomes from April 15, 2022 to April 15, 2025. Through the grant funding, UCLA will conduct research to transform health care for service members and the public by investigating medical solutions for the battlefield....
This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
The University of California, Los Angeles (UCLA) was awarded a $662,086 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2022 to April 30, 2025 to investigate NUDT5 as a novel target for ovarian cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goal of transforming health care for...
The University of California, Los Angeles will receive $1,153,194 under a Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) to optimize radiation delivery and dissect the response to radiation for patients with localized prostate cancer. The research aims to transform health care for service members and the public through innovative medical solutions for the battlefield and investigations into innovative radiation...
The University of California, Los Angeles (UCLA), through its Office of Research Administration, was awarded a $1,366,628 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into the role of oxidative mitochondrial metabolism in resistance to androgen receptor inhibition from July 1, 2023 to June 30, 2026. As the prime awardee, UCLA will leverage its research facilities and faculty...
The Department of the Army Medical Command awarded a $2.28 million Project Grant to the University of California, Los Angeles to support research titled "Identification of Spatial Regulatory Heterogeneity in Prostate Cancer Using Single-Nucleus Joint Profiling of Chromatin Architecture and DNA Methylation." The research will be conducted from June 2022 to June 2025 under the Military Medical Research and Development program (CFDA 12.420). This program supports basic, applied, and...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $630,000.00 to the University of California, Los Angeles (UCLA) for intravesical nectin4 chimeric antigen receptor T cell therapy research for non-muscle invasive bladder cancer. The award period runs from September 1, 2024 to August 31, 2026. As the prime awardee, UCLA will leverage its facilities, faculty expertise, and administrative capabilities...
The University of California, Los Angeles (UCLA) was awarded a $961,089 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research targeting mitochondrial defects in kidney cancer from September 1, 2022 to August 31, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...